Visceral leishmaniasis (VL ... and the clinical presentation of VL is not sufficiently specific to guide treatment. Highly accurate (both sensitive and specific), cheap and simple rapid diagnostic ...

Current treatments require daily injections for up to 17 days which can cause pain, nausea and vomiting, and the new study is ...

In February 2023, a different drug, orlistat, was approved in Japan as the first over-the-counter medicine for the reduction of visceral fat in the treatment of obesity. Orlistat is a lipase ...

Marsolais. “By distinguishing between and targeting both excess visceral abdominal fat and generalized obesity, treatment strategies can be tailored to address the specific needs of people ...

Both presentations focus on issues surrounding excess visceral abdominal fat (EVAF), a common comorbidity in people with HIV (PWH). One poster presents a new analysis of data from the Visceral ...

The researchers concluded that increased levels of visceral fat – more so than subcutaneous fat or increasing BMI – strongly correlate with reduced skeletal muscle quality, which may amplify ...

Tropical disease Visceral leishmaniasis is a tropical disease found in swathes of Asia, East Africa, and Brazil, and is ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

A compound derived from Nectandra leucantha, a tree native to southern Brazil (local names canela-seca or canela-branca), has ...

This article is authored by Dr Tanu Jain, director, National Centre for Vector Borne Disease Control (NCVBDC), New Delhi.

These results were verified through CT scan and weight measurement, demonstrating significant reductions in visceral fat deposits following treatment. In addition to these clinical outcomes, ...